On May 27, 2016，Amyris companies in the United States，invited by Prof. Lin Zhanglin, the senior director of the research and development department, Dr Zhao Lishan visited School of Bioscience and Bioengineering, SCUT for academic exchanges and cooperation.
Amyris company, one of the first synthetic biology company, was listed on the United States NASDQ, which is founded by Jay Keasling, who is recognized as one of the iconic figure in the field of synthetic biology. The company is dedicated to the application of industrial production of pharmaceuticals, fine chemicals of high performance synthetic biology platform and oil fuel alternatives.
Dr. Zhao Lishan gave an academic report in the topic of Industrialization of Synthetic Biology: Qinghaosu (artemisinin) and beyond, introduced in detail how to use Synthetic Biology technology, the automation platform, build efficient production in saccharomyces cerevisiae anti-malarial drugs - artemisinin precursor artemisinic acid synthesis pathway, and the successful case of Industrialization; He also introduced how to use the new design idea of synthetic biology, refactoring in saccharomyces cerevisiae is more important than the nature better chemical method, olefin synthetic ways; Dr. Zhao shared his experience, from the laboratory to the process of industrialization and technology management experience.
Teachers, graduate and undergraduate students participated in the heated discussion. Some researchers from several other universities in Guangdong Province, such as Jinan university, Shenzhen Institute of Advanced Technology of Chinese Academy of Sciences, Shenzhen University, Shenzhen Second People's Hospital also attended Dr. Zhao Lishan’s report.
The visit of Dr. Zhao boosted the development of synthesis biology in our school and help to construct the international communication in synthesis biology.